The interplay between CKD, sudden cardiac death, and ventricular arrhythmias

Advances in Chronic Kidney Disease

Volumn 21, Issue 6, 2014, Pages 480-488

  Pun, Patrick H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmias; CKD; Dialysis; Implantable cardioverter defibrillators; Sudden cardiac death

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUDDEN CARDIAC DEATH; ADVERSE EFFECTS; ANIMAL; COMPLICATION; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE; HYPERKALEMIA; HYPOKALEMIA; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

ANIMALS; ARRHYTHMIAS, CARDIAC; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART VENTRICLES; HUMANS; HYPERKALEMIA; HYPERTROPHY, LEFT VENTRICULAR; HYPOKALEMIA; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84927593570     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.06.007     Document Type: Review

References (88)

1. Herzog C.A., Asinger R.W., Berger A.K., et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011, 80(6):572-586.
2. Pun P.H., Smarz T.R., Honeycutt E.F., Shaw L.K., Al-Khatib S.M., Middleton J.P. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009, 76(6):652-658.
3. Goldenberg I., Moss A.J., McNitt S., et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006, 98(4):485-490.
4. Saxon L.A., Bristow M.R., Boehmer J., et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Circulation 2006, 114(25):2766-2772.
5. Deo R., Lin F., Vittinghoff E., Tseng Z.H., Hulley S.B., Shlipak M.G. Kidney dysfunction and sudden cardiac death among women with coronary heart disease. Hypertension 2008, 51(6):1578-1582.
6. Deo R., Sotoodehnia N., Katz R., et al. Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes 2010, 3(2):159-164.
7. USRDS Annual Data Report 2005, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
8. Herzog C.A. Can we prevent sudden cardiac death in dialysis patients?. Clin J Am Soc Nephrol 2007, 2(3):410-412.
9. USRDS Annual Data Report 2010, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
10. USRDS Annual Data Report 2006, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
11. Pun P., Lehrich R.W., Smith S.R., Middleton J.P. Predictors of survival following cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2007, 2:491-500.
12. Karnik J.A., Young B.S., Lew N.L., et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001, 60(1):350-357.
13. Lai M., Hung K., Huang J., Tsai T. Clinical findings and outcomes of intra-hemodialysis cardiopulmonary resuscitation. Am J Nephrol 1999, 19(4):468-473.
14. Moss A.H., Holley J.L., Upton M.B. Outcomes of cardiopulmonary resuscitation in dialysis patients. J Am Soc Nephrol 1992, 3(6):1238-1243.
15. Eknoyan G., Beck G.J., Cheung A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002, 347(25):2010-2019.
16. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005, 353(3):238-248.
17. Parekh R.S., Plantinga L.C., Kao W.H., et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 2008, 74:1335-1342.
18. Wang A.Y., Lam C.W., Chan I.H., Wang M., Lui S.F., Sanderson J.E. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension 2010, 56(2):210-216.
19. Jadoul M., Thumma J., Fuller D.S., et al. Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2012, 7(5):765-774.
20. Myerburg R.J., Castellanos A. Cardiac Arrest and Sudden Cardiac Death: Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine 2005, Elsevier Saunders, Philadelphia, PA.
21. Pratt C.M., Greenway P.S., Schoenfeld M.H., Hibben M.L., Reiffel J.A. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation 1996, 93(3):519-524.
22. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114(10):e385-484.
23. Ritz E., Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 2008, 3(3):920-929.
24. Herzog C.A. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int Suppl 2003, 84:S197-S200.
25. Bleyer A.J., Hartman J., Brannon P.C., Reeves-Daniel A., Satko S.G., Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006, 69(12):2268-2273.
26. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 2001, 345(20):1473-1482.
27. Bayes de Luna A., Coumel P., Leclercq J.F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989, 117(1):151-159.
28. Ohtake T., Kobayashi S., Moriya H., et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005, 16(4):1141-1148.
29. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18(9):1731-1740.
30. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15(5):458-482.
31. Kalantar-Zadeh K., Block G., Humphreys M.H., Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003, 63(3):793-808.
32. Zager P.G., Nikolic J., Brown R.H., et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998, 54(2):561-569.
33. Yamada S., Ishii H., Takahashi H., et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol 2010, 5(10):1793-1798.
34. Park M., Hsu C.Y., Li Y., et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012, 23(10):1725-1734.
35. Mangrum A.J., Liu D., Dimarco J.P., Bolton K., Mangrum M. Sudden cardiac death and left ventricular function in hemodialysis patients. Heart Rhythm 2005, 2(5):S41.
36. Paoletti E., Specchia C., Di Maio G., et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004, 19(7):1829-1834.
37. Mark P.B., Johnston N., Groenning B.A., et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006, 69(10):1839-1845.
38. Schietinger B.J., Brammer G.M., Wang H., et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging 2008, 1(4):450-456.
39. Amann K., Breitbach M., Ritz E., Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998, 9(6):1018-1022.
40. Amann K., Ritz E., Wiest G., Klaus G., Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994, 4(10):1814-1819.
41. Burton J.O., Jefferies H.J., Selby N.M., McIntyre C.W. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009, 4(5):914-920.
42. Foley R.N., Gilbertson D.T., Murray T., Collins A.J. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011, 365(12):1099-1107.
43. Pun P.H., Lehrich R.W., Honeycutt E.F., Herzog C.A., Middleton J.P. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 2011, 79(2):218-227.
44. Movilli E., Gaggia P., Zubani R., et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007, 22(12):3547-3552.
45. Saran R., Bragg-Gresham J.L., Levin N.W., et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006, 69(7):1222-1228.
46. Flythe J.E., Brunelli S.M. The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care. Semin Dial 2011, 24(3):259-265.
47. Morris S.T., Galiatsou E., Stewart G.A., Rodger R.S., Jardine A.G. QT dispersion before and after hemodialysis. J Am Soc Nephrol 1999, 10(1):160-163.
48. Beaubien E.R., Pylypchuk G.B., Akhtar J., Biem H.J. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis 2002, 39(4):834-842.
49. Gabutti L., Ferrari N., Giudici G., Mombelli G., Marone C. Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis. Nephrol Dial Transplant 2003, 18(11):2369-2376.
50. Di Iorio B., Torraca S., Piscopo C., et al. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. J Nephrol 2012, 25(5):653-660.
51. Pande S.R., R, Bloom E., Chewaproug D., Dissanayake I. Effect of dialysate baths on serum bicarbonate levels in hemodialysis patients. Am J Kidney Dis 2011, 57(4):A75.
52. Tentori F., Karaboyas A., Robinson B.M., et al. Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2013, 62(4):738-746.
53. Hayes J., Kalantar-Zadeh K., Lu J.L., Turban S., Anderson J.E., Kovesdy C.P. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract 2012, 120(1):c8-c16.
54. Spooner P.M. Sudden cardiac death: the larger problem.. The larger genome. J Cardiovasc Electrophysiol 2009, 20(5):585-596.
55. Bonato F.O., Lemos M.M., Cassiolato J.L., Canziani M.E. Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients. PLoS One 2013, 8(6):e66036.
56. Wan C., Herzog C.A., Zareba W., Szymkiewicz S.J. Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol 2013, 19(3):247-257.
57. Hsueh C.-H.C., Neal X., Chen P.-S., Lin S.F., Moe S.M. Increased inducibility of ventricular arrhythmia in a rat model of chronic kidney disease. J Am Soc Nephrol 2013, 24:139A.
58. Davis T.R., Young B.A., Eisenberg M.S., Rea T.D., Copass M.K., Cobb L.A. Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 2008, 73(5):933-939.
59. Takeda K., Harada A., Okuda S., et al. Sudden death in chronic dialysis patients. Nephrol Dial Transplant 1997, 12:952-955.
60. Pun P.H., Schumm D., Sanders G.D., et al. A pilot study using an implantable device to characterize cardiac arrhythmias in hemodialysis patients: implications for future research. Ann Noninvasive Electrocardiol 2012, 17(2):159.
61. Lehrich R., Pun P.H., Tanenbaum N.D., Smith S.R., Middleton J.P. Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. J Am Soc Nephrol 2007, 18:312-320.
62. Drechsler C., Krane V., Winkler K., Dekker F.W., Wanner C. Changes inadiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int 2009, 76(5):567-575.
63. Shastri S., Tangri N., Tighiouart H., et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol 2012, 7:123-130.
64. Passman R., Herzog C.A. End-stage renal disease: sudden cardiac death: stratifying risk in dialysis patients. Nat Rev Nephrol 2011, 7(3):133-135.
65. Ganesh S.K., Stack A.G., Levin N.W., Hulbert-Shearon T., Port F.K. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12(10):2131-2138.
66. Cice G., Ferrara L., D'Andrea A., et al. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 2003, 41(9):1438-1444.
67. Tangri N., Shastri S., Tighiouart H., et al. Beta-blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO study. Am J Kidney Dis 2011, 58(6):939-945.
68. Agarwal R., Sinha A.D., Pappas M.K., Abraham T.N., Tegegne G.G. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant 2014, 29(3):672-681.
69. Baigent C., Landray M.J., Reith C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011, 377:2181-2192.
70. Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009, 360(14):1395-1407.
71. Mann J.F., Gerstein H.C., Pogue J., Bosch J., Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001, 134(8):629-636.
72. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345(12):861-869.
73. Iseki K., Arima H., Kohagura K., et al. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial. Nephrol Dial Transplant 2013, 28(6):1579-1589.
74. Zannad F., Kessler M., Lehert P., et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006, 70(7):1318-1324.
75. Tai D.J., Lim T.W., James M.T., Manns B.J., Tonelli M., Hemmelgarn B.R. Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. Clin J Am Soc Nephrol 2010, 5(4):623-630.
76. Santoro A., Mancini E., London G., et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrol Dial Transplant 2008, 23(4):1415-1421.
77. Pun P.H., Horton J.R., Middleton J.P. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 2013, 8(5):797-803.
78. Mendoza J.M., Bayes L.Y., Sun S., Doss S., Schiller B. Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study. Am J Kidney Dis 2011, 58(6):956-963.
79. Jefferies H.J., Burton J.O., McIntyre C.W. Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif 2011, 32(1):63-68.
80. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010, 363(24):2287-2300.
81. Pun P.H., Al-Khatib S.M., Han J.Y., et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis 2014, 64(1):32-39.
82. Sakhuja R., Keebler M., Lai T.S., McLaughlin Gavin C., Thakur R., Bhatt D.L. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009, 103(5):735-741.
83. Dasgupta A., Montalvo J., Medendorp S., et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007, 49(5):656-663.
84. Wase A., Basit A., Nazir R., et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004, 11(3):199-204.
85. Drew D.A., Meyer K.B., Weiner D.E. Transvenous cardiac device wires and vascular access in hemodialysis patients. Am J Kidney Dis 2011, 58(3):494-496.
86. Charytan D.M., Patrick A.R., Liu J., et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011, 58(3):409-417.
87. Herzog C.A., Li S., Weinhandl E.D., Strief J.W., Collins A.J., Gilbertson D.T. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005, 68(2):818-825.
88. Pun P.H., Middleton J.P. Sudden cardiac death in hemodialysis patients: a comprehensive care approach to reduce risk. Blood Purif 2012, 33(1-3):183-189.